Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Jon Michael Harrison

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4416-8086; OpenAlex author ID A5052748399. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
62
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 3 papers · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 9

  1. Neoadjuvant Chemotherapy With or Without Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2026.3716↗
  2. Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. Co-author DOI 10.1158/2767-9764.crc-24-0392↗
  3. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival. Co-author DOI 10.1016/j.gassur.2024.02.018↗
  4. Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer. First author DOI 10.1158/2767-9764.crc-23-0489↗
  5. A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: Th… Co-author DOI 10.1097/sla.0000000000004143↗
  6. Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. Co-author DOI 10.1097/sla.0000000000005433↗
  7. Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cance… Co-author DOI 10.3390/cancers14040868↗
  8. Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoad… Co-author DOI 10.1245/s10434-020-09444-z↗
  9. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoad… Co-author DOI 10.1245/s10434-019-08084-2↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keith D. Lillemoe · 8 shared papers, 2020–2026 · strength 1.22
  2. Motaz Qadan · 7 shared papers, 2020–2026 · strength 1.02
  3. Carlos F. Fernandez-del Castillo · 6 shared papers, 2020–2025 · strength 0.91
  4. Cristina Rosa Ferrone · 5 shared papers, 2020–2024 · strength 0.70
  5. Theodore Sunki Hong · 4 shared papers, 2020–2026 · strength 0.54
  6. Jennifer Yon-Li Wo · 4 shared papers, 2020–2026 · strength 0.54
  7. Andrew Louis Warshaw · 3 shared papers, 2022–2025 · strength 0.47
  8. Mari A. Mino-Kenudson · 3 shared papers, 2022–2025 · strength 0.47
  9. Taisuke Baba · 3 shared papers, 2022–2025 · strength 0.44
  10. Louisa Bolm · 3 shared papers, 2022–2025 · strength 0.44
  11. Kim C. Honselmann · 3 shared papers, 2022–2025 · strength 0.44
  12. Natalie Petruch · 3 shared papers, 2022–2025 · strength 0.44
  13. Carlos Fernández-del Castillo · 3 shared papers, 2022–2026 · strength 0.43
  14. David Tsai Ting · 2 shared papers, 2024–2025 · strength 0.35
  15. Andrew Scott Liss · 2 shared papers, 2024–2025 · strength 0.35
  16. Hiroki Sato · 2 shared papers, 2022–2024 · strength 0.33
  17. Thomas P. Hank · 2 shared papers, 2022–2025 · strength 0.33
  18. Marta Sandini · 2 shared papers, 2022–2025 · strength 0.33
  19. David P. Ryan · 2 shared papers, 2022–2026 · strength 0.32
  20. Colin D. Weekes · 2 shared papers, 2022–2026 · strength 0.32
  21. Lawrence Scott Blaszkowsky · 2 shared papers, 2020–2026 · strength 0.30
  22. Theodoros P. Michelakos · 2 shared papers, 2021–2022 · strength 0.24
  23. Tobias Keck · 2 shared papers, 2022 · strength 0.23
  24. Ulrich Friedrich Wellner · 2 shared papers, 2022 · strength 0.23
  25. Susan Kuo · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.